The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(isoquinolin-4-ylethynyl)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-(trifluoromethyl)benzamide ID: ALA4082034
PubChem CID: 86567539
Max Phase: Preclinical
Molecular Formula: C32H26F6N4O
Molecular Weight: 596.58
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCN(Cc2ccc(NC(=O)c3ccc(C(F)(F)F)c(C#Cc4cncc5ccccc45)c3)cc2C(F)(F)F)CC1
Standard InChI: InChI=1S/C32H26F6N4O/c1-41-12-14-42(15-13-41)20-25-8-10-26(17-29(25)32(36,37)38)40-30(43)22-9-11-28(31(33,34)35)21(16-22)6-7-24-19-39-18-23-4-2-3-5-27(23)24/h2-5,8-11,16-19H,12-15,20H2,1H3,(H,40,43)
Standard InChI Key: NGICBKLUYGHCJP-UHFFFAOYSA-N
Molfile:
RDKit 2D
43 47 0 0 0 0 0 0 0 0999 V2000
11.8667 -7.4982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1663 -7.9176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4528 -7.5157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7525 -7.9351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7615 -8.7522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4750 -9.1540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1754 -8.7346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8535 -6.6811 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.5802 -7.8959 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2846 -7.4806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2715 -6.6636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9718 -6.2442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6853 -6.6419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6985 -7.4590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9940 -7.8783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3898 -6.2225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1033 -6.6202 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1123 -7.4373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8258 -7.8391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5262 -7.4198 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.5171 -6.6027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8036 -6.2050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2397 -7.8175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0349 -7.5374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3214 -7.1397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1850 -5.9425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8853 -5.5231 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5988 -5.9249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6079 -6.7420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9075 -7.1573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9207 -7.9743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2162 -8.3937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5027 -7.9960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4937 -7.1789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1940 -6.7596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9581 -5.4228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9466 -4.6793 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.6116 -4.8730 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.2879 -4.8936 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.0583 -9.1725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4184 -9.5512 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.2568 -8.8776 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.9312 -10.0169 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
2 7 2 0
1 8 2 0
1 9 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
17 22 1 0
20 23 1 0
16 17 1 0
13 16 1 0
9 10 1 0
24 25 3 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
26 35 1 0
30 35 2 0
25 29 1 0
4 24 1 0
36 37 1 0
36 38 1 0
36 39 1 0
12 36 1 0
40 41 1 0
40 42 1 0
40 43 1 0
5 40 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 596.58Molecular Weight (Monoisotopic): 596.2011AlogP: 6.67#Rotatable Bonds: 4Polar Surface Area: 48.47Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 7.62CX LogP: 6.50CX LogD: 6.07Aromatic Rings: 4Heavy Atoms: 43QED Weighted: 0.21Np Likeness Score: -1.23
References 1. Liu Y, Peng X, Guan X, Lu D, Xi Y, Jin S, Chen H, Zeng L, Ai J, Geng M, Hu Y.. (2017) Discovery of novel Ponatinib analogues for reducing KDR activity as potent FGFRs inhibitors., 126 [PMID:27750146 ] [10.1016/j.ejmech.2016.10.003 ]